GENERATION BIO CO's ticker is GBIO and the CUSIP is 37148K100. A total of 86 filers reported holding GENERATION BIO CO in Q1 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atlas Venture Life Science Advisors, LLC | 8,278,876 | $32,535,983 | 3.92% |
GREAT POINT PARTNERS LLC | 1,022,537 | $4,018,570 | 0.79% |
Artal Group S.A. | 2,814,191 | $11,060 | 0.62% |
SVB FINANCIAL GROUP | 52,920 | $207,976 | 0.57% |
PFM Health Sciences, LP | 2,903,192 | $11,409,545 | 0.41% |
Cheyne Capital Management (UK) LLP | 51,126 | $200,925 | 0.35% |
HighVista Strategies LLC | 138,880 | $545,798 | 0.32% |
HARVARD MANAGEMENT CO INC | 510,354 | $2,005,691 | 0.25% |
SECTORAL ASSET MANAGEMENT INC | 273,787 | $1,075,983 | 0.21% |
Yiheng Capital Management, L.P. | 1,186,295 | $4,662,139 | 0.21% |